Eye Diseases: News and Research on Orbital Diseases

MeSH tree: C11.675

US biopharma firm Amgen to acquire Horizon Therapeutics for $28 bn

US biopharmaceutical firm Amgen said Monday it has reached agreement to acquire Horizon Therapeutics, which specializes in medicine for rare and auto-immune diseases, for $27.8 billion.

Dec 12, 2022

0

49

Consensus statement on management of thyroid eye disease

The American Thyroid Association (ATA) and European Thyroid Association (ETA) have collaborated on the "Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and European Thyroid Association." ...

Dec 9, 2022

0

76

page 3 from 3

• «
• »